Gene therapy for Parkinson's disease: state-of-the-art treatments for neurodegenerative disease.

about

Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.Focusing brain therapeutic interventions in space and time for Parkinson's disease.Preconditioning as a potential strategy for the prevention of Parkinson's disease.

P2860

Q36164724-48A09D24-8D88-4D2A-805A-51FB371331FF Q36745293-05BD5E23-D419-44C0-A811-077631CDB7D0 Q38201685-8E5906C5-DBDC-47C9-8EE1-DD2D81E11054

P2860

Gene therapy for Parkinson's disease: state-of-the-art treatments for neurodegenerative disease.

Item

http://www.wikidata.org/entity/Q38112216

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Gene therapy for Parkinson's d ...... for neurodegenerative disease.

@en

type

Item

label

Gene therapy for Parkinson's d ...... for neurodegenerative disease.

@en

prefLabel

Gene therapy for Parkinson's d ...... for neurodegenerative disease.

@en

P1476

Gene therapy for Parkinson's d ...... for neurodegenerative disease.

@en

P2093

Michael R Douglas

http://www.w3.org/2001/XMLSchema#string

P2860

Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy

Neurturin, a relative of glial-cell-line-derived neurotrophic factor

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Genetics of Parkinson's disease

Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

P304

695-705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERN.13.58

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23739006

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

neurodegeneration

gene therapy

Gene therapy for Parkinson's disease: state-of-the-art treatments for neurodegenerative disease.

about

P2860

P2860

Gene therapy for Parkinson's disease: state-of-the-art treatments for neurodegenerative disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921